The Zinn Company plans to issue $10,000,000 of 20-year bonds in June to help finance a new research and development laboratory. The bonds will pay interest semiannually. It is now November, and the current cost of debt to the high-risk biotech company is 11%. However, the firm"s financial manager is concerned that interest rates will climb even higher in coming months. The following data are available:futures Prices: Treasury Bonds—$100,000; Pts. 32nds of 100%
DeliveryMonth(1)
Open(2)
High(3)
Low(4)
Settle(5)
Change(6)
OpenInterest(7)
Dec
94"28
95"13
94"22
95"05
+0"07
591,944
Mar
96"03
95"25
+0"08
120,353
June
95"03
95"17
13,597
Already registered? Login
Not Account? Sign up
Enter your email address to reset your password
Back to Login? Click here